BLBausch + Lomb BLCO · NYSE
$20.01 +0.03% (+$0.01)
- Market cap
- $7.15B
- Enterprise value
- $6.68B
- P/E
- -
- Forward P/E
- 23.0x
- PEG
- -
- P/S
- 1.3x
- P/FCF
- 28.2x
- EV/EBITDA
- 9.7x
- ROIC
- 97.3%
- Gross margin
- 58.6%
- Net margin
- -2.1%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- -0.7x
- Beta
- 0.56
- Free float
- 12.8%
About the company
Bausch + Lomb Corporation is a Canadian global company specializing in the development, manufacturing, and marketing of healthcare products, particularly in the field of ophthalmology and eye care. The company offers a wide range of products, including contact lenses, eye drops, surgical instruments for eye surgeries, and medications for treating various eye conditions. Bausch + Lomb also focuses on the development of advanced eye technologies and providing comprehensive vision care for patients worldwide. The company is known for its long-standing tradition and expertise in eye medicine.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Thomas J. Appio
Employees
13,000
Headquarters
Vaughan
Valuation
Is today's price reasonable?
- What to watch: The share price is above the Bulios Fair Price.
Growth and estimates
Is it growing, and what comes next?
- What speaks for it: Revenue grew by 11% a year over the last 3 years.
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
- What speaks for it: It earns 97 USD a year on every 100 USD of invested capital.
- What to watch: The company made a loss over the last 12 months.
Financial health
Can it carry its debt?
- What speaks for it: It holds more cash than debt: $513.0M against $45.0M.
- What to watch: Operating profit does not even cover the interest on its debt.
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number